Integer Holdings Appoints Payman Khales as CEO—Strategic Continuity Set to Drive Innovation

Planned Leadership Change Marks Smooth Transition at Integer Holdings

Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization, announced today that Payman Khales has officially assumed the role of President and Chief Executive Officer. The transition was part of a long-planned leadership shift, following the retirement of former CEO Joseph Dziedzic after eight years at the helm. Dziedzic will remain as an advisor through March 31, 2026, ensuring knowledge transfer and continued strategic oversight.

Track Record of Accelerated Growth and Operational Excellence

Khales’ elevation comes after his impressive stint as President of Integer’s Cardio & Vascular business, where he successfully doubled sales within seven years, surpassing industry benchmarks in growth and profitability. More recently, as Chief Operating Officer, he steered Integer’s global business units and operations, bolstering the company’s standing as a premier partner to medical device OEMs worldwide.

Industry-Focused Strategy Remains a Priority

Khales is clear about the company’s trajectory: continuing to innovate alongside customers and delivering transformative medical technologies. His message of value creation through collaboration and customer-centric strategies echoes his tenure in previous roles—signaling a continued focus on above-market growth and operational discipline. This strategic continuity is likely to reassure stakeholders seeking stability amid industry changes.

Executive Background Reinforces Confidence

Prior to joining Integer, Khales held key positions at CECO Environmental Corp. and Ingersoll Rand Company. He holds an Executive MBA from Indiana University's Kelley School of Business and a Bachelor’s in Mechanical Engineering from École Polytechnique de Montréal—blending technical expertise with operational leadership. His proven background makes him well-equipped to tackle the complexities of the competitive medical device manufacturing landscape.

What to Watch Moving Forward

For investors and industry observers, the transition at Integer Holdings reflects more than just a change in title. With Khales at the helm, the company’s recent momentum in sales growth and operational improvements is expected to continue. The ongoing advisory role of Dziedzic through early 2026 provides additional assurance of steady stewardship.

The market will be watching for signals on Khales’ priorities in his first quarters as CEO—especially on innovation pipelines, global partnerships, and service quality metrics. As Integer positions itself to remain a top strategic partner for OEMs, Khales’ approach to sustaining above-market performance could provide valuable insight for stakeholders in the months ahead.

Contact Information for Stakeholders

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.

About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.

NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.

The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.

Disclosure: This article was generated with the assistance of AI